Open Access 01-12-2022 | Rituximab | Correction
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Published in: Pediatric Rheumatology | Issue 1/2022
Login to get access